Investing.com - Legend Bio (NASDAQ: LEGN) reported third quarter EPS of $-0.34, worse than the analyst estimate of $-0.33. Revenue for the quarter came in at $160.21M versus the consensus estimate of $142.93M.
Legend Bio's stock price closed at $40.04. It is down -29.62% in the last 3 months and down -38.06% in the last 12 months.
Legend Bio saw 0 positive EPS revisions and 3 negative EPS revisions in the last 90 days. See Legend Bio's stock price’s past reactions to earnings here.
According to InvestingPro, Legend Bio's Financial Health score is "fair performance".
Check out Legend Bio's recent earnings performance, and Legend Bio's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar